Liquid biopsy: A game-changer for cancer diagnosis and therapy

Medicover Genetics Editorial Team|

Scientifically checkedView our editorial guidelines
Scientifically checked

Liquid biopsy is a novel, non-invasive blood test that enables healthcare providers to discover a range of information about a tumour, such as early cancer detection, genetic alterations that lead to cancer development and therapy resistance, as well disease monitoring. It has the potential to revolutionise cancer care and management and identify new therapeutic avenues.

Our latest infographic describes the use of liquid biopsy, its clinical significance, and how it can be a game-changer for cancer diagnosis and therapy.

Topics covered in this infographic:

  • What is liquid biopsy?
  • The biocomponents that liquid biopsy can detect, focusing on ctDNA which has been in the spotlight for its clinical value
  • What information the ctDNA can provide?
  • The uses of liquid biopsy
  • Recommendations from researchers and professional bodies about liquid biopsy
  • How liquid biopsy compares to traditional tumour biopsy
  • genetic test for therapy selection

Last updated: 14.09.2026

Latest articles

All about genetics
Health and well-being
Hereditary diseases

  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • ebiom+

    A comprehensive assessment of the endometrial microbiome and chronic endometritis pathogens to enhance clinical outcomes, prevent treatment delays, and support a more informed, personalised fertility care.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Why Medicover Genetics

Leader in genetic testing with >25 years of experience in counselling and diagnostics

Comprehensive CE-IVD kit portfolio and seamless Technology Transfer solution for laboratories of any size

End-to-end clinical workflow from sample processing to sequencing analysis and reporting

CAP- and CLIA- and ISO15189 accredited, GMP- and ISO9001 and 13485 certified

Are you a patient?

Are you a physician?